FDA committee date for Natpara BLA delayed

NPS Pharmaceuticals Inc. (NASDAQ:NPSP) said FDA shifted the tentative date to Sept. 12 from July 24 for an Endocrinologic and Metabolic Drugs Advisory Committee meeting to discuss the biotech's BLA fo...